Analystreport

GlaxoSmithKline plc (NYSE: GSK) had its "hold" rating re-affirmed by analysts at Cowen Inc. They now have a $45.00 price target on the stock.

GSK plc American Depositary Shares (Each representing two Ordinary Shares)  (GSK) 
US:NYSE Investor Relations: gsk.com/en-gb/investors